如果您要报告不良事件或产品投诉,请拨打礼来客户服务中心热线400-828-2059(手机),800-828-2059(座机)
在 monarchE 3 期临床研究中用于评估高危早期乳腺癌患者的标准化研究性 Ki-67 免疫组织化学分析确定了单独接受内分泌治疗时疾病复发风险更高的人群
返回A Standardized Investigational Ki-67 Immunohistochemistry Assay Used to Assess High-Risk Early Breast Cancer Patients in the monarchE Phase 3 Clinical Study Identifies a Population With Greater Risk of Disease Recurrence When Treated With Endocrine Therapy Alone
作者：Polewski, Monika D; Nielsen, Gitte B; Gu, Ying ; Weaver, Aaron T; Gegg, Gavin; Tabuena-Frolli, Siena; Cajaiba, Mariana; Hanks, Debra; Method, Michael; Press, Michael F; Gottstein, Claudia; Gruver, Aaron M.期刊：Applied Immunohistochemistry & Molecular Morphology卷/期/页码：April 2022 - Volume 30 - Issue 4 - p 237-245
